Drug-Diagnostics Co-Development in Oncology
The idea of combining drugs and diagnostics in oncology is not new. When the selective estrogen receptor modulator tamoxifen was developed in the 1970’s for the treatment of breast cancer a positive correlation between receptor status and treatment outcome was found. As a result of this research, it...
Сохранить в:
| Главный автор: | |
|---|---|
| Формат: | Online |
| Язык: | английский |
| Опубликовано: |
Frontiers Media SA
2021
|
| Предметы: | |
| Online-ссылка: | 18664 |
| Метки: |
Нет меток, Требуется 1-ая метка записи!
|